Tonic-clonic epilepsy treatment adjunct

Tonic-clonic epilepsy describes a central nervous system disorder characterized by recurrent, major convulsive seizures originating either from widespread bilateral cerebral networks or secondary to focal seizure generalization Clinically, these episodes manifest with an abrupt loss of consciousness, sustained widespread muscular rigidity during the tonic phase, and subsequent rhythmic, synchronous jerking spasms throughout the clonic phase, frequently followed by profound postictal depression

Tonic-clonic epilepsy describes a central nervous system disorder characterized by recurrent, major convulsive seizures originating either from widespread bilateral cerebral networks or secondary to focal seizure generalization

The designation of a treatment adjunct specifies the use of an add-on therapeutic agent administered alongside established baseline antiseizure regimens

The designation of a treatment adjunct specifies the use of an add-on therapeutic agent administered alongside established baseline antiseizure regimens This adjunctive treatment setting is indicated when primary baseline pharmacotherapies fail to achieve adequate seizure control in affected pediatric or adult populations

This adjunctive treatment setting is indicated when primary baseline pharmacotherapies fail to achieve adequate seizure control in affected pediatric or adult populations